Search Results - Fangxin Hong
- Showing 1 - 2 results of 2
-
1
Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis by Leslie S. Wilson, Traci M. Blonquist, Fangxin Hong, Barbara Halpenny, Seth Wolpin, Peter Chang, Christopher P. Filson, Viraj A. Master, Martin G. Sanda, Gary W. Chien, Randy A. Jones, Tracey L. Krupski, Donna L. Berry
Published in BMC Medical Informatics and Decision Making (2019-01-01)Get full text
Article -
2
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status by Mark Awad, Mizuki Nishino, Mehmet Altan, Biagio Ricciuti, Fangxin Hong, Matthew Hellmann, John V Heymach, Joao V Alessi, Elizabeth Jiménez-Aguilar, Zihan Wei, Andrew J Plodkowski, Peter Sawan, Jia Luo, Hira Rizvi, Brett W Carter
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article
